ASMB
Assembly Biosciences·NASDAQ
--
--(--)
--
--(--)
ASMB fundamentals
Assembly Biosciences (ASMB) released its earnings on Nov 10, 2025: revenue was 10.79M (YoY +57.62%), beat estimates; EPS was -0.72 (YoY +52.32%), beat estimates.
Revenue / YoY
10.79M
+57.62%
EPS / YoY
-0.72
+52.32%
Report date
Nov 10, 2025
EPS
Actual | -9.12 | 2.28 | -1.08 | -13.2 | -8.28 | -6.6 | -4.92 | -16.2 | -5.76 | -6.12 | -5.76 | -5.4 | -4.44 | -3.84 | -3.24 | -1.86 | -1.66 | -1.98 | -1.51 | -1.54 | -1.17 | -1.33 | -0.72 | ||||||||
Forecast | -11.73 | -0.36 | -9 | -10.54 | -9.26 | -7.92 | -6.8229 | -5.832 | -5.496 | -5.52 | -4.44 | -4.76 | -4.16 | -3.36 | -2.82 | -2.82 | -3.23 | -2.23 | -2.3033 | -1.795 | -1.6 | -1.73 | -0.8213 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +22.25% | +733.33% | +88.00% | -25.24% | +10.58% | +16.67% | +27.89% | -177.78% | -4.80% | -10.87% | -29.73% | -13.45% | -6.73% | -14.29% | -14.89% | +34.04% | +48.61% | +11.21% | +34.44% | +14.21% | +26.88% | +23.12% | +12.33% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 4.08M | 39.38M | 34.61M | 1.00M | 0 | 0 | 6.25M | 0 | 0 | 0 | -- | 0 | 0 | 0 | 0 | 7.20M | 5.79M | 8.53M | 6.84M | 7.36M | 9.42M | 9.63M | 10.79M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 3.82M | 30.54M | 6.44M | 3.97M | 2.51M | 1.63M | 0 | 1.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.00M | 5.77M | 3.55M | 7.41M | 5.30M | 7.46M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +6.92% | +28.92% | +437.84% | -74.82% | -100.00% | -100.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +42.22% | +18.70% | +107.32% | +27.03% | +81.67% | +44.64% |
Earnings Call
You can ask Aime
What does Assembly Biosciences do and what are its main business segments?What guidance did Assembly Biosciences's management provide for the next earnings period?What factors drove the changes in Assembly Biosciences's revenue and profit?What is the revenue and EPS growth rate for Assembly Biosciences year over year?Did Assembly Biosciences beat or miss consensus estimates last quarter?What is Assembly Biosciences's gross profit margin?What were the key takeaways from Assembly Biosciences’s earnings call?What were the key takeaways from Assembly Biosciences's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
